Comparison of 5-, 10-, and 15-point laparoscopic ovarian electrocauterization in patients with polycystic ovarian disease: a prospective, randomized study.
OBJECTIVE
We compared 12-month pregnancy and live birth rates in patients with polycystic ovarian disease undergoing 5-, 10-, and 15-point laparoscopic ovarian electrocauterization.


METHODS
This was a prospective, randomized study performed at the Dabirashrafi Fertility and Endoscopy Research Center, Tehran, Iran. The study included 187 patients with polycystic ovarian disease who were randomly assigned to 3 groups. Group I comprised 67 patients whose ovaries received 5-point electrocauterization. Group II comprised 57 patients whose ovaries received 10-point electrocauterization. Group III comprised 63 patients whose ovaries received 15-point electocauterization. Laparoscopic ovarian electrocauterization with a unipolar current was used. The main outcome measures were 12-month pregnancy and live birth rates.


RESULTS
Patients were homogeneous for age, body mass index, and type and duration of infertility. Twenty pregnancies resulted in Group I, with a pregnancy rate of 29.9% (20/67) and a live birth rate of 20.9% (14/57). Eighteen pregnancies resulted in Group II, with a pregnancy rate of 31.6% (18/57), and a live birth rate of 28.1% (16/57). Thirty-three pregnancies resulted in group III, with a pregnancy rate of 52.4% (33/63), and a live birth rate of 47.6% (30/63). Comparison of Group III with Groups I and II revealed a statistically significant increase in pregnancies (P=0.016) and live birth rates (P=0.004).


CONCLUSIONS
We recommend 15-point electrocauterization of ovaries in patients with polycystic ovarian disease.
Tabrizi
Nasrin Moghadami
NM
Dabirashrafi Fertility and Endoscopy Research Center Tehran, Iran.
Mohammad
Kazem
K
Dabirashrafi
Hormoz
H
Nia
Fahime Iravani
FI
Salehi
Parisa
P
Dabirashrafi
Babak
B
Shams
Shahram
S
D000328:Adult; D004564:Electrocoagulation / Q000379:methods*; D005260:Female; D006801:Humans; D010535:Laparoscopy; D011085:Polycystic Ovary Syndrome / Q000628:therapy*; D011446:Prospective Studies; D016896:Treatment Outcome